NASDAQ : KALA
-$0.18 (-17.76%)
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Avi Minkowitz |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | KALA |
| CUSIP | 483119301 |
| CIK | 0001479419 |
| Web | https://www.kalarx.com |
| Phone | 781 996 5252 |
| Currency | USD |
| Employees | 6 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 7.91 |
| Quick Ratio | 7.91 |
| Cash Ratio | 1.13 |
Sales & Book Value
| Annual Sales | -$ |
| Price / Sales | 0.00 |
| Cash Flow | -3.20 |
| Price / Cash Flow | -0.87 |
| Price / Book | 0.78 |
Price Target and Rating
| Average Stock Price Forecast | $18.25 |
| High Stock Price Forecast | $35.00 |
| Low Stock Price Forecast | $1.50 |
| Forecast Upside/Downside | -95.36% |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 11 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$3.31 |
| Trailing P/E Ratio | -0.36 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | -$26.98M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | -1335.64% |
| Return on Assets | -159.56% |
Financials Score
| AltmanZ Score | -74.65 |
| Piotroski Score | 2.00 |
| Working Capital | 10.76M |
| Total Assets | 12.32M |
| Ebit | -17.47M |
| Market Cap | 21.13M |
| Total Liabilities | 1.56M |
About KALA BIO, Inc. (NASDAQ:KALA) Stock
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts. ...
KALA BIO Announces Reverse Stock Split
2026-05-07 09:00:00
ARLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the “common stock”) at a ratio of 1 post-split share for every 50 pre-split shares.
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
2026-04-21 07:00:00
ARLINGTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA” or the “Company”) today celebrated the landmark Executive Order signed by U.S. President Donald J.
Frequently Asked Questions
What is the current KALA BIO, Inc. (KALA) stock price?
KALA BIO, Inc.(NASDAQ:KALA) stock price is $0.8471 in the last trading session. During the trading session, KALA stock reached the peak price of $1030 while $0.83 was the lowest point it dropped to. The percentage change in KALA stock occurred in the recent session was --17.76% while the dollar amount for the price change in KALA stock was -$0.18.
KALA's industry and sector of operation?
The NASDAQ listed KALA is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of KALA?
Mary Reumuth
| Treasurer & Secretary
Vincent Kosewski
| Senior Vice President of Manufacturing & Supply Chain Management
Jill S. Steier
| Executive Director of Investor Relations & Corporation Communications
Francis S. Mah
| Chief Medical Advisor
Justin Hanes
| Founder & Chair of the Scientific Advisory Board
How many employees does KALA have?
Number of KALA employees currently stands at 6. KALA operates from 1167 Massachusetts Avenue, Arlington, MA 02476, US.
Link for KALA official website?
Official Website of KALA is: https://www.kalarx.com
How do I contact KALA?
KALA could be contacted at phone #781 996 5252 and can also be accessed through its website. KALA operates from 1167 Massachusetts Avenue, Arlington, MA 02476, US.
How many shares of KALA are traded daily?
The average number of KALA shares traded daily for last 3 months was 132.93K.
What is the market cap of KALA currently?
The market value of KALA currently stands at $18.58M with its latest stock price at $0.8471